Our technology has been used in several studies in the past few years. Our involvement in these studies aims to showcase the range of different applications our technology can be used for. Each pilot study contributes to improving our understanding of the capability and flexibility of our technology, while also exploring new opportunities and applications in the field.

Scientific material

A Comparative Study on Direct vs Indirect Labelling of Biomarkers using SCIZYS Erbium
May 2026. White paper jointly presented by Lumito and Atlas Antibodies.
Modernisation of Immunohistochemistry: Standardised Controls and a Novel Nanoparticle Labelling System
January 2026. Poster presented at the 2026 Winter Meeting of The Pathological Society of Great Britain & Ireland.
A Novel Technique for Enhanced Detection of HER2-Low Using Photon Upconverting Nanoparticles
October 2025. White paper presented by Lumito AB.
Capturing the Full Spectrum: High Dynamic Range Biomarker Detection with Photon Upconverting Nanoparticles
June 2025. Poster presented at EACR 2025 in Lisbon. 
In vitro generation of Langerhans cells useful in an immune competent in vitro 3D skin model
May 2025. Poster by Malmö University.
A Novel Technique for Enhanced Detection of HER2-Low Using Photon Upconverting Nanoparticles
May 2025. Poster presented by Lumito at ESMO Breast Cancer 2025 in Munich.
A Novel Tool for Immunohistochemistry: SCIZYS by Lumito
June 2024. White paper presented by Lumito AB.
High contrast breast cancer biomarker semi-quantification and immunohistochemistry imaging using upconverting nanoparticles
January 2024. Scientific paper by Konugolu et al in Biomed. Opt. Express 15, 900-909 (2024). 
Upconversion Nanoparticles as labels for histopathological tissue evaluation
September 2023. Poster presented by Lumito. 
Utility of Upconversion Nanoparticles (UCNP) Based Immunohistochemistry in Diagnostic Renal Biopsies – A Proof of Concept Study
July 2023. Poster presented by University Hospital Coventry and Warwickshire (UHCW) NHS Trust, Coventry, UK. 
Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer
January 2023. Scientific paper by Lidström et al in Cancer Immunol Res (2023) 11 (1): 72–92.

Presentation

A presentation about a study in pancreatic cancer using Lumito’s imaging technology